Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phenoxodiol receives fast track status for recurrent ovarian cancer

Nov. 9, 2004

New approval for Eloxatin

Nov. 9, 2004

Histone deacetylase inhibitor effective against esophageal carcinoma in vitro

Nov. 9, 2004

Taxotere approved in E.U. for prostate cancer

Nov. 8, 2004

Natural protease inhibitors may enhance chemotherapeutic efficacy

Nov. 8, 2004

Novel TGF-beta receptor type II kinase inhibitors claimed by Pfizer

Nov. 8, 2004

New inhibitors of PDE4, MMP and/or TNF-alpha discovered at Celgene

Nov. 8, 2004

New anticancer and immunostimulant agent isolated from plants by Japanese team

Nov. 8, 2004

Femara approved for post-tamoxifen treatment of early breast cancer

Nov. 5, 2004

ChemGenex plans phase II study of Quinamed in prostate cancer

Nov. 5, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...